<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     The Schedule Contains Summary Financial  Information Extracted From Balance
     Sheets and Statements of Income
</LEGEND>
<CIK>                         0000878616
<NAME>                        Human Pheromone Sciences, Inc.
<MULTIPLIER>                                   1

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                             761,000
<SECURITIES>                                             0
<RECEIVABLES>                                    1,223,000
<ALLOWANCES>                                       (38,000)
<INVENTORY>                                        600,000
<CURRENT-ASSETS>                                 2,593,000
<PP&E>                                             802,000
<DEPRECIATION>                                    (793,000)
<TOTAL-ASSETS>                                   2,602,000
<CURRENT-LIABILITIES>                              597,000
<BONDS>                                                  0
                                    0
                                      3,606,000
<COMMON>                                        17,667,000
<OTHER-SE>                                    (19,268,000)
<TOTAL-LIABILITY-AND-EQUITY>                     2,602,000
<SALES>                                          1,755,000
<TOTAL-REVENUES>                                 2,284,000
<CGS>                                              686,000
<TOTAL-COSTS>                                      686,000
<OTHER-EXPENSES>                                 1,939,000
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                  22,000
<INCOME-PRETAX>                                  (361,000)
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                              (361,000)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                     (361,000)
<EPS-BASIC>                                         (0.11)
<EPS-DILUTED>                                       (0.11)



</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission